SCHEMBL7366502

SCHEMBL7366502

COc1cc(C(=O)c2c(F)cccc2F)ccc1OCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.65
RAB9A P51151 3/20 0.65
HPGD P15428 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
SMPD1 P17405 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
KDM4E B2RXH2 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
ATM Q13315 1/20 0.56
MRGPRX4 Q96LA9 5/20 0.55
RXRA P19793 1/20 0.54
CTSV O60911 1/20 0.54
CTSL P07711 1/20 0.54
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
ABCB1 P08183 1/20 0.52
ACHE P22303 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7365989 0.89 NPC1 (0.64) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL7373028 0.89 NPC1 (0.64) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL27881765 0.88 NPC1 (0.77) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL7370570 0.86 ATM (0.69) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL242563 0.83 MRGPRX4 (0.77) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL7372360 0.82 NPC1 (0.68) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL7371119 0.81 MRGPRX4 (0.64) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL11277266 0.81 MRGPRX4 (0.75) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL31025721 0.81 NPC1 (0.75) NPC1RAB9AHPGDSMN1; SMN2SMPD1
SCHEMBL340620 0.81 NPC1 (0.75) NPC1RAB9AHPGDSMN1; SMN2SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed